Icelandic Salmon AS Overview
Icelandic Salmon AS is a Norwegian-incorporated holding company whose sole operating asset, Arnarlax ehf., is one of Iceland's two largest Atlantic salmon farmers and historically the country's largest by harvest volume. Controlled by SalMar ASA (52.5%), the world's second-largest salmon farmer, it operates a fully integrated egg-to-market value chain in the Westfjords and on Iceland's south coast: four smolt facilities, sea farms in Arnarfjörður, Patreksfjörður and Tálknafjörður under 23,700 tonnes of maximum allowed biomass (MAB), a 30,000-tonne harvesting plant in Bíldudalur, and an in-house sales organisation shipping fresh salmon to Europe, North America and Asia. After record years in 2022–2023 (16–18 thousand tonnes harvested; operational EBIT up to EUR 36m), the group suffered two years of biological setbacks, a licence revocation and losses. 2026 is positioned as a recovery year (21,300 tonnes guided), but regulatory and fiscal uncertainty in Iceland has led management to freeze its 26,000-tonne growth plan.
Company's own description (paraphrased from 1H 2026 report and Q2 2026 presentation): Icelandic Salmon AS is the sole owner and parent of Arnarlax ehf., through which all operating activities are carried out. The group describes itself as fully integrated: it procures salmon eggs for its hatcheries, produces its own smolt and post-smolt, farms salmon in sea pens, harvests and processes in its own plant, and sells and distributes "sustainable Icelandic salmon" through an internal sales department to Europe, North America and the Far East. The stated purpose is the production, processing and sale of seafood and seafood-based products. The group reports a single operating segment.
Business model. The business is a biologically driven commodity-producer model. Value is created by converting purchased eggs and feed into harvestable salmon over a roughly 2.5–3-year production cycle (approximately 12–18 months in freshwater/post-smolt plus 12–20 months at sea), constrained by regulatory MAB licences. Revenue is a function of harvest volume × achieved price; profitability is a function of the spread between achieved price and full production cost per kg (feed, smolt, sea-lice treatment, mortality, harvesting, freight, production tax).
Revenue model mix (FY2025 and 1H 2026, EUR thousands):
Product sales account for over 99% of revenue. There is no subscription or licensing income. Fixed-price contract share is low (6% in Q2 2026; 10% expected for FY2026), so the company is highly exposed to spot salmon prices (source: Q2 2026 presentation).
Value chain position. Upstream: purchases eggs (currently from Benchmark Genetics' Icelandic operation StofnFiskur; applications filed in Sept 2026 to add Norway's AquaGen as an approved source) and feed (supplier not disclosed). Midstream: owns smolt production, sea farming and primary processing (harvest plant). Downstream: sells primarily head-on gutted fresh salmon to importers, processors, wholesalers and retail-linked buyers; it does not operate significant secondary processing or consumer brands at retail scale.
Customer types. Seafood importers/distributors, secondary processors (fillet and smoked salmon producers), wholesale and food-service channels in Europe; importers serving US retail/food-service; Asian importers (China notably cited) buying larger fish. Specific customer names are not publicly disclosed. Normal credit terms are 21 days (1H 2026 report, Note 2).
End-markets (share of fish-sales revenue, company data):
(Source: 1H 2026 report key-figures page. 2023 Asia derived as residual. The same report's Note 2 shows FY2025 as 67/15/17 and the presentation chart shows 1H 2026 as 65/15/20 — rounding discrepancies.)
Independent characterisation. Icelandic Salmon is best understood as a sub-scale but structurally advantaged single-country salmon producer that sits inside SalMar's operating system. Its advantages — low-lice cold waters by Norwegian standards, geothermal-assisted smolt production, proximity to US and European airfreight lanes through Keflavík, and a premium "Icelandic origin" narrative — are offset by Iceland's harsh winter conditions (winter ulcers, storms), an immature and politically contested regulatory regime, a rising resource tax, and a concentrated licence base of only three fjords. Earnings are extremely volatile: operational EBIT swung from EUR 36.2m (2022) to minus EUR 18.2m (2025) on broadly similar revenue scale, illustrating how biology and cost-per-kg dominate the P&L. The equity story since 2024 has shifted from "Iceland growth platform" to "operational recovery under regulatory uncertainty."
Strategy
Stated strategy themes (paraphrased from 1H 2026 report and annual reports)
-
Sustainable growth "on the salmon's terms" — growth in harmony with nature; 100% ASC-certified sea production and BRCGS-certified harvesting.
-
Full value-chain control — self-sufficiency in smolt and post-smolt; own harvesting capacity in Bíldudalur; all sales through an in-house department.
-
Post-smolt strategy — larger smolts (130–700 g; 5.1m smolts planned for release in 2026) to shorten sea time and improve survival through the first winter.
-
Low-cost producer ambition — combining biological best practice with cost efficiency; ongoing cost-saving programme.
-
Licence-base expansion — re-obtain 10,000 t sterile-salmon licence in Ísafjarðardjúp; expand five Arnarfjörður sites.
-
Leadership in Iceland's aquaculture industry — stated aim to be the leader of the sector and a contributor to local communities.
-
Culture and organisation — values of leadership in salmon farming, quality, teamwork and care.
Strategic initiatives (last 24 months)
| Initiative | Date | Description | Status / targets |
|---|---|---|---|
| Cost-saving programme | 2025–H2 2026 | Group-wide initiatives; positive effect on operational cost reported in H1 2026 | Continuing into H2 2026; no quantified target disclosed |
| Growth plan to 26,000 t | Announced 2024–25; on hold Aug 2026 | Targeted long-term investment plan to fully utilise production capacity (26 kt) | Frozen due to regulatory uncertainty; FY2026 capex cut to EUR 4.1m |
| Laxabraut post-smolt facility | Ongoing | South-coast post-smolt expansion | Completion expected Q1 2027 |
| Non-medicinal lice control | June 2026 | Service vessel with FLS delicing system operational; complements Stingray lasers and lice skirts; medicinal treatment minimised | Operational |
| Genetics diversification | Sept 2026 | MAST proposed licence amendments adding AquaGen as an approved egg source for two Arnarlax facilities, Fjallalax (Hallkelshólar) and Ísþór (Þorlákshöfn) | Consultation closed 7 Oct 2026; final decision pending |
| Ísafjarðardjúp sterile salmon | 2024–ongoing | Re-approval of 10,000 t MAB sterile-salmon licence (three sites) | "Significant progress" in 2026; timing undetermined |
| Arnarfjörður expansion | 2,026 | Application to expand five existing sites | Timing undetermined |
| Sales platform monetisation | H1 2026 | Third-party producer outsourced sales to Arnarlax | Ongoing |
| Market-mix shift | 2025–26 | Growing Asia/North America share via larger fish | Asia 21% of H1 2026 revenue |
| EU customs adaptation | Nov 2024 | Arnarlax Europe ApS for in-transit sales | Operational |
| Sustainability-linked financing | 2023–25 | EUR 100m SLL (2023), upsized to EUR 160m (2025), amended Sept 2025 | KPIs not disclosed in sources reviewed |
Management guidance / medium-term targets
| Item | Guidance | Source |
|---|---|---|
| Harvest volume FY2026 | 21,300 tonnes (unchanged since Q4 2025 report; initially 21,000 t at Q3 2025) | Q2 2026 presentation |
| Cost level | Lower in Q3 2026 vs Q2 2026 as 2025 generation harvesting begins | Q2 2026 presentation |
| MAB utilisation | Better in 2026, positive cost effect | Q2 2026 presentation |
| Contract share FY2026 | About 10% | Q2 2026 presentation |
| Capex FY2026 | EUR 4.1m | Q2 2026 earnings summary |
| Long-term volume potential | 26,000 t on existing licences (smolt capacity for 25–30 kt) — now on hold | 1H 2026 report; Annual Report 2024 |
| Financial targets (margin, ROCE) | — | — |
Products & Services
The group is a mono-product producer. The catalogue below lists every product and service category disclosed or evidenced.
Note: one aggregator (roic.ai) describes smoked-salmon products and processing partnerships in Ireland and Spain.
Product Portfolio
| # | Product / service | Description & specifications | Target customer | Launch / latest | Pricing model |
|---|---|---|---|---|---|
| 1 | Fresh whole Atlantic salmon, head-on gutted (HOG) | Core product; harvested and packed at Bíldudalur; graded by weight class; fresh on ice, shipped by truck/ferry to Europe and by air to US/Asia | Importers, processors, wholesalers | Ongoing | Predominantly spot, referenced to market prices (e.g., NASDAQ/SISALMON, Fish Pool); 6% fixed contracts in Q2 2026, 10% expected FY2026 |
| 2 | Large-size salmon (6+ kg) | Premium size class; drove higher North America (16%) and Asia (19%) volume shares in Q2 2026 | US and Chinese buyers of large fish | Ongoing | Spot, size premium |
| 3 | Fresh salmon fillets | Company reported rising demand for fillets in 2022 (Q4 2022 release); current volumes not disclosed | US / European buyers | c.2022 | — |
| 4 | Frozen salmon / downgraded fish | Frozen whole salmon and lower-grade fish (e.g., after biological incidents) listed in inventory categories | Processors | Ongoing | Spot, discount to superior grade |
| 5 | "Arnarlax – Sustainable Icelandic Salmon" brand | Common brand for all products, launched 2021; origin and sustainability positioning (ASC, BRCGS) | Trade buyers, retail partners | 2,021 | Brand premium not quantified |
| 6 | Harvesting services | Third-party harvesting at Bíldudalur (plant capacity 30 kt vs own 21 kt guided volume) | Other Westfjords farmers | Ongoing | Fee-based; within "other revenues" (EUR 0.5m FY2025) |
| 7 | Sales and marketing services | Since H1 2026, a third-party salmon producer has outsourced its sales to the Arnarlax sales team | Other Icelandic producers | 2,026 | — |
| 8 | Sludge sales | Sale of aquaculture sludge to processing companies | Processors (fertiliser/biogas) | Ongoing | — |
| 9 | Employee accommodation leasing | Rental income from staff housing | Employees | Ongoing | Lease |
| 10 | Arctic char (legacy) | Biological asset category still includes "arctic char fish at cost" (Fjallalax origin) | — | Legacy | — |
“—” = not publicly disclosed.
Financial Narrative
Income statement
Sources: 1H 2026 report (multi-year key figures, FY2025 income statement and APM note); Q4 2022 release (FY2021–22 operational EBIT/kg). FY2023–24 operational EBIT/kg, revenue/kg, gross profit, operational EBITDA (operational EBIT + D&A of EUR 13.9m) and CAGR derived. Dividends: no ordinary dividend paid for financial years 2021–2025 (ex-dividend entries of NOK 0.00 each year; AGM 2026 resolved no dividend for 2025).
Margins (%):
(Derived from figures above.)
FY2025 income statement detail (EUR thousands; Annual Report 2025 comparatives in 1H 2026 report):
Note the presentation: the income tax line is shown as negative EUR 9.0m while net loss (EUR 24.8m) is smaller than pre-tax loss (EUR 33.8m), meaning the tax line represents a tax income (deferred tax benefit) of approximately EUR 9.0m despite the sign shown. The same applies to H1 2026 (tax effect EUR 2.2m).
Commentary — income statement. The five-year arc is a boom-and-bust in volume and unit margin. Revenue rose 73% in 2022 on +40% harvest and strong prices, and edged up in 2023 to a peak of EUR 164.8m on record volume. Operational EBIT, however, peaked a year earlier (2022, EUR 36.2m, EUR 2.24/kg) and halved in 2023 as costs rose and the Q4 2023 Tálknafjörður lice crisis forced early harvests. The 2024 collapse (harvest −35%, revenue −38%) reflected biological losses in the winter of 2023–24 and the deliberate holding back of biomass. 2025 was worse on margin despite +9% volume: all Q2–Q3 2025 harvest came from the high-cost 2023 generation, extraordinary biological costs were recognised, and achieved revenue per kg fell to about EUR 7.10 amid weaker global prices. The inflection is visible from Q4 2025 (operational EBIT +EUR 0.70/kg) and Q1 2026 (near break-even), with Q2 2026 again negative (−EUR 0.59/kg) due to BKD at one site from the 2024 generation (EUR 2.2m extraordinary cost in the quarter, EUR 3.0m YTD). The decisive driver for the next 12 months is whether the well-performing 2025 generation, harvested from Q3 2026, delivers the lower cost per kg management expects.
Balance sheet
Sources: 1H 2026 report key-figures charts (assets, equity ratio, NIBD, leases, biomass), FY2025 balance sheet, statement of changes in equity (equity 1 Jan 2025 = EUR 149.8m), Q4 2022 release (equity 2022 EUR 144m, up EUR 35m from 2021). FY2025 net working capital derived as current assets ex cash (122.8) minus non-interest-bearing current liabilities (17.0) — note current liabilities include EUR 7.9m of current debt/leases which are excluded. FY2023 equity not directly verified (equity ratio × assets would imply approx. EUR 152m, shown as n/a to avoid estimation). The FY2025 equity ratio is 45% in the key-figure chart but "47%" in the narrative text; arithmetic (124.98/278.36) gives 44.9%.
Commentary — balance sheet. The balance sheet has been levered up to finance biomass rebuilding and smolt-capacity investment while earnings turned negative. NIBD ex-leases rose from EUR 45.8m (2023) to EUR 116.6m (2025) — a 2.5x increase — while equity fell by about EUR 25m in 2025 alone. The equity ratio dropped from 64% to 45% (43% at 30 June 2026), uncomfortably closer to the 35% covenant floor. Biological assets are the dominant current asset (EUR 109.5m at YE2025), meaning the balance sheet is exposed to fair-value swings driven by forward salmon prices and to incident-based mortality write-downs. Goodwill of EUR 34.7m (from historical combinations, primarily the Fjarðalax transaction) represents 28% of equity. Licences are carried at only EUR 1.7m — far below economic value, as Icelandic licences were largely granted rather than purchased — implying meaningful hidden asset value if licences are ever transacted.
Cash flow
Sources: Annual Report 2025 via 1H 2026 report cash-flow comparatives; FCF derived. No dividends or buybacks were executed in the period (AGM records; no buyback execution disclosed).
Commentary — cash flow. 2025 was a heavy cash-burn year: operating cash flow was negative EUR 22.1m as EUR 18.5m was absorbed into biomass at cost (closing biomass rose to 18.1kt lwt from 12.8kt), plus negative operating earnings. The deficit was financed by EUR 45m of new bank drawings. H1 2026 marks a clear inflection: operating cash flow turned positive (EUR 13.4m) as biomass was harvested down (biological assets fell EUR 11.9m) and price achievement improved, while capex was cut to EUR 1.6m (full-year 2026 plan EUR 4.1m, down from earlier growth-plan levels). NIBD fell by EUR 7m in Q2 2026 alone. The sustainability of positive FCF depends on margins rather than working-capital release, as biomass will need to be rebuilt for 2027 harvests.
Ratios
Derived by analyst. ROE = net income / average equity (149.8, 125.0); ROA = net income / average assets (263.2, 278.4); ROIC approximated as operational EBIT (pre-tax) / average (equity + NIBD incl. leases); net debt/EBITDA not meaningful in FY2025 as operational EBITDA was negative. Cash conversion cycle: not meaningful/not disclosed — for salmon farmers the economic cycle is dominated by a 2–3-year biomass build, not receivables/payables.
Commentary — ratios. Returns were deeply negative in 2025. The high current ratio is misleading: it reflects biomass carried as a current asset, not liquidity (cash was only EUR 7.3m at YE2025; available liquidity, including undrawn facilities, was EUR 46m at 30 June 2026 and EUR 52m at 30 Sept 2025). Leverage relative to equity has more than doubled since 2023. Interest coverage was negative in 2025, which is why the original ICR and leverage covenants had to be waived.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Registered office | Owner | Ownership | Function |
|---|---|---|---|---|
Icelandic Salmon AS | Kverva, Norway | Listed; SalMar 52.48% | — | Listed holding company |
Arnarlax ehf. | Strandgata 1, 465 Bíldudalur, Iceland | Icelandic Salmon AS | 100% | All operations: farming, harvesting, sales |
Fjallalax ehf. | Bíldudalur (site at Hallkelshólar, south Iceland) | Arnarlax ehf. | 100% | Geothermal smolt facility; 100 t MAB; approx. 1.3m smolts/yr |
Eldisstöðin Ísþór ehf. | Nesbraut 25, 815 Þorlákshöfn | Arnarlax ehf. | 100% | Smolt/large-smolt facility; 2,700 t MAB; 3.3–4.0m smolts/yr at 130–700 g |
Icelandic Salmon ehf. | Bíldudalur | Arnarlax ehf. | 100% | Dormant; retained to preserve name rights |
Arnarlax Europe ApS | Lautrupsgade 11, Copenhagen | Arnarlax ehf. | 100% | EU entity enabling in-transit sales under EU customs rules |
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Segment revenue (EUR Mn) | 164.8 | 101.5 | 90.0 |
Segment operational EBIT (EUR Mn) | 20.3 | -5.9 | -18.2 |
Operational EBIT margin (%) | 12.3 | -5.8 | -20.2 |
Revenue YoY growth (%) | 4.6 | -38.4 | -11.3 |
Share of group revenue (%) | 100 | 100 | 100 |
Harvest volume (thousand tgw) | 17.9 | 11.7 | 12.7 |
Operational EBIT per kg (EUR) | 1.13 | -0.50 | -1.44 |
Function Details
| Function | Assets | Capacity |
|---|---|---|
Smolt | Gileyri (Westfjords), Ísþór (Þorlákshöfn), Fjallalax (Hallkelshólar), Laxabraut 5 (south coast; post-smolt expansion due Q1 2027) | Sufficient for 25–30 kt harvest |
Seawater | Sites in Arnarfjörður, Patreksfjörður, Tálknafjörður | 23,700 t MAB; 6–8 sites (company documents vary: "six", "seven ASC-certified", "eight") |
Harvesting | Bíldudalur plant, BRCGS-certified | 30,000 t/yr |
Sales | In-house sales team; Arnarlax Europe ApS | Domestic and global |
Revenue by Segment and Unit Economics (EUR/kg)
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|
Revenue (EUR Mn) | 10.5 | 25.0 | 25.1 | 29.4 | 26.9 | 39.9 |
Operational EBIT (EUR Mn) | -3.0 | -8.3 | -9.4 | 2.6 | -0.1 | -3.2 |
Harvest (thousand tgw) | 1.1 | 4.0 | 3.8 | 3.8 | 3.7 | 5.5 |
Operational EBIT per kg (EUR) | — | -2.09 | -2.48 | 0.70 | -0.02 | -0.59 |
Income Statement and Unit Economics (EUR/kg)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (EUR Mn) | 90.8 | 157.6 | 164.8 | 101.5 | 90.0 |
Harvest volume (thousand tgw) | 11.5 | 16.1 | 17.9 | 11.7 | 12.7 |
Revenue per kg harvested (EUR) | 7.90 | 9.79 | 9.21 | 8.68 | 7.10 |
Gross profit after COGS (EUR Mn) | — | — | — | — | 31.9 |
Operational EBIT (EUR Mn) | 7.3 | 36.2 | 20.3 | -5.9 | -18.2 |
Operational EBIT per kg (EUR) | 0.63 | 2.24 | 1.13 | -0.50 | -1.44 |
Operational EBITDA (EUR Mn) | — | — | — | — | -4.3 |
Production tax (EUR Mn) | — | — | — | — | -3.9 |
Fair value adjustment of biomass (EUR Mn) | — | — | — | — | -2.8 |
Operating profit IFRS (EUR Mn) | — | — | — | — | -25.2 |
Net financial items (EUR Mn) | — | — | — | — | -8.6 |
Pre-tax income (EUR Mn) | — | — | — | — | -33.8 |
Net income (EUR Mn) | — | — | — | — | -24.8 |
EPS basic and diluted (EUR) | — | — | — | — | -0.80 |
Dividend per share (NOK) | — | 0 | 0 | 0 | 0 |
Revenue CAGR FY2021–FY2025 (%) | — | — | — | — | -0.2 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin after COGS (%) | — | — | — | — | 35.5 |
Operational EBIT margin (%) | 8.0 | 23.0 | 12.3 | -5.8 | -20.2 |
Operational EBITDA margin (%) | — | — | — | — | -4.8 |
Net margin (%) | — | — | — | — | -27.6 |
Business Lines
| Line | FY2025 |
|---|---|
Total operating revenue | 89,976 |
Cost of goods sold | (58,058) |
Salaries and personnel | (17,050) |
Other operating expenses | (19,173) |
Depreciation and amortisation | (13,886) |
Restructuring cost | (369) |
Production tax | (3,873) |
Fair value adjustment of biomass | (2,777) |
Operating profit | (25,210) |
Financial income | 362 |
Financial expense | (8,926) |
Net currency gain/(loss) | (45) |
Profit before tax | (33,819) |
Income tax | (9,005) |
Net profit | (24,813) |
Balance Sheet and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (EUR Mn) | 171.0 | 235.3 | 238.3 | 263.2 | 278.4 |
Equity ratio (%) | 64 | 61 | 64 | 57 | 45 |
Total equity (EUR Mn) | 109 | 144 | — | 149.8 | 125.0 |
Cash and equivalents (EUR Mn) | — | — | — | 6.9 | 7.3 |
Interest-bearing debt to banks (EUR Mn) | — | — | — | — | 123.9 |
— of which short-term (EUR Mn) | — | — | — | — | 3.0 |
— of which long-term (EUR Mn) | — | — | — | — | 120.9 |
Net interest-bearing debt ex leases (EUR Mn) | 36.8 | 56.0 | 45.8 | 75.6 | 116.6 |
Lease liabilities (EUR Mn) | 5.9 | 6.9 | 5.7 | 11.2 | 12.4 |
NIBD incl. leases (EUR Mn) | 42.7 | 63.0 | 51.5 | 86.8 | 129.0 |
Goodwill (EUR Mn) | — | — | — | — | 34.7 |
Licences (intangible, EUR Mn) | — | — | — | — | 1.7 |
Biological assets (EUR Mn) | — | — | — | — | 109.5 |
Closing biomass (thousand t lwt) | 14.0 | 14.9 | 9.6 | 12.8 | 18.1 |
Net working capital ex cash (EUR Mn) | — | — | — | — | 105.0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansCash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (EUR Mn) | — | — | — | — | -22.1 |
Capex (EUR Mn) | — | — | — | — | -6.5 |
Free cash flow (EUR Mn) | — | — | — | — | -28.6 |
Dividends paid (EUR Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (EUR Mn) | 0 | 0 | 0 | 0 | 0 |
New interest-bearing debt drawn (EUR Mn) | — | — | — | — | 45.0 |
Debt repayments (EUR Mn) | — | — | — | — | -3.0 |
Lease principal paid (EUR Mn) | — | — | — | — | -4.6 |
Interest paid (EUR Mn) | — | — | — | — | -8.5 |
Cash Flow (Half-Yearly)
| Metric | H1 2025 | H1 2026 |
|---|---|---|
Operating cash flow (EUR Mn) | -10.8 | 13.4 |
Capex (EUR Mn) | -5.7 | -1.6 |
Free cash flow (EUR Mn) | -16.5 | 11.8 |
Net financing cash flow (EUR Mn) | 14.8 | -8.6 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2024 | FY2025 |
|---|---|---|---|---|
ROE (%) | — | — | — | -18.1 |
ROA (%) | — | — | — | -9.2 |
ROIC operational EBIT based (%) | — | — | — | -7.4 |
Current ratio (x) | — | — | — | 5.2 |
Debt to equity incl. leases (x) | — | — | — | 1.09 |
Interest coverage operational EBIT/financial expense (x) | — | — | — | -2.0 |
Asset turnover (x) | — | — | — | 0.33 |
NIBD incl. leases to equity (x) | 0.39 | 0.44 | 0.58 | 1.03 |
Revenue by Region
| Region | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Europe (EUR Mn) | 123.6 | 69.0 | 60.6 |
North America (EUR Mn) | 31.3 | 16.2 | 13.8 |
Asia (EUR Mn) | 9.9 | 16.2 | 15.5 |
Total (EUR Mn) | 164.8 | 101.5 | 90.0 |
Revenue by Region (%)
| Region | FY2024 YoY | FY2025 YoY |
|---|---|---|
Europe (%) | -44.2 | -12.2 |
North America (%) | -48.2 | -14.8 |
Asia (%) | 63.6 | -4.3 |
Revenue by Region (Half-Yearly)
| Region | H1 2025 | H1 2026 | Growth (%) |
|---|---|---|---|
Europe (EUR Mn) | 27.2 | 43.2 | 59.1 |
North America (EUR Mn) | 4.8 | 9.6 | 100.1 |
Asia (EUR Mn) | 3.5 | 13.8 | 292.2 |
Valuation Snapshot
| Metric | Value | Source / note |
|---|---|---|
Recent share price | approx. | Alphaspread; roic.ai |
Price at 30 Jun 2026 | NOK 66.0 | 1H 2026 report |
Price at start of 2026 | NOK 79 (−16.5% YTD to end June) | 1H 2026 report |
Price 3 Oct 2025 | NOK 88.40 | Simply Wall St |
52-week change | approx. −30% | roic.ai |
Oct 2020 placement price | NOK 115 | Fish Farming Expert |
Market capitalisation | approx. NOK 2.0–2.2bn (approx. EUR 170–190m) | Derived from 30.96m shares |
Enterprise value | approx. EUR 295–315m (market cap + NIBD incl. leases EUR 123.7m) | Derived |
LTM revenue (Jul 2025–Jun 2026) | EUR 121.3m | Derived (FY2025 − H1 2025 + H1 2026) |
EV/Sales LTM | approx. 2.5x | Derived |
P/B | approx. 1.5x (book equity EUR 116.0m) | Derived |
P/E | Not meaningful (loss-making) | — |
EV/EBITDA | Not meaningful (LTM operational EBITDA approx. EUR 3.8m, derived) | — |
EV per tonne MAB | approx. EUR 12,500–13,300 | Derived (23,700t) |
Capital Markets
| Item | Detail |
|---|---|
Number of analysts | 4–5 (Simply Wall St, 2025) |
Price targets | NOK 90 consensus (Oct 2025, Simply Wall St); range NOK 90–103 (TradingView snapshot, date uncertain) — both likely stale relative to Aug 2026 results |
Capital Markets (Annual)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividend per share (NOK) | 0 | 0 | 0 | 0 | 0 |
Capital Instruments
| Instrument | Amount | Currency | Maturity / terms |
|---|---|---|---|
Bank borrowings — non-current | 119,514 | EUR | — |
Bank borrowings — current instalments | 3,000 | EUR | EUR 1.5m semi-annual instalments (EUR 3.0m per year) |
Lease liabilities | 11,599 | NOK 7,188 / ISK 4,411 | EUR 4,259 due within 12 months |
Cash | (10,385) | Mixed | — |
NIBD ex leases | 112,130 | — | — |
NIBD incl. leases | 123,729 | — | — |
Available liquidity | approx. 46,000 | — | Q2 2026 presentation |
Analyst Conclusions
Management guidance (as of 25 Aug 2026)
| Item | Guidance |
|---|---|
| FY2026 harvest | 21,300 t (vs 12,671 t in 2025) |
| Q3 2026 cost | Lower than Q2 2026; 2025 generation harvest from Q3 2026 |
| MAB utilisation | Improved, positive cost effect |
| FY2026 contract share | About 10% |
| FY2026 capex | EUR 4.1m (EUR 1.6m spent H1) |
| US tariffs | Reduced to 0% |
| Growth to 26,000 t | On hold pending regulatory clarity |
| Implied H2 2026 harvest | approx. 12,100 t (derived: 21,300 − 9,201) |
TradingView data (date uncertain) showed analysts expecting continued per-share losses in the near term.
Bull case
-
Volume and cost recovery are underway: H1 2026 harvest +81% YoY and operational EBIT/kg improved from minus EUR 2.23 to minus EUR 0.36; the well-performing 2025 generation should lower cost from Q3 2026, and H2 implies about 12kt — the largest half-year since 2023.
-
Licence optionality is mispriced: EV of about EUR 12.5–13.3k per tonne of MAB is low relative to Norwegian licence values; re-approval of the 10kt Ísafjarðardjúp sterile licence would add 42% capacity, and the Arnarfjörður licence is now secured for 16 years.
-
Commercial tailwinds: US tariffs at 0%, Asia demand for large fish (Asia +292% in H1 2026), and Q1 2027 forward prices of EUR 8.20/kg support a strong winter-quarter result; SalMar backing reduces refinancing tail risk.
Bear case
-
Biology keeps recurring: three consecutive years of material biological incidents (lice 2023, 2024 setbacks, BKD 2026) suggest structurally higher cost and risk than modelled; another bad winter would threaten 2027 volumes.
-
Balance sheet and covenants: NIBD incl. leases of EUR 124m against negligible trailing operational EBITDA, equity ratio at 43% with a 35% floor, and covenant step-downs at 30 Sep 2026 and 31 Mar 2027 could force further waivers or an equity raise (likely led by SalMar, diluting minorities at depressed prices).
-
Iceland policy risk is rising, not falling: the aquaculture bill failed, the production fee keeps increasing (+59% YoY in H1 2026), and management has frozen growth — the core equity story of a growth platform is on hold indefinitely.
Key catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable |
|---|---|
| Oct–Nov 2026 | Q3 2026 harvest/results: cost per kg of 2025 generation; 30 Sep covenant test outcome |
| Q4 2026 | MAST decision on AquaGen egg-source amendments |
| Q4 2026–2027 | Ísafjarðardjúp sterile-salmon licence re-approval |
| 2026–2027 | Re-introduction and passage of Iceland's aquaculture law; production-fee trajectory |
| Feb 2027 | Q4 2026 results; FY2026 delivery vs 21.3kt guidance; 2027 guidance |
| Q1 2027 | Laxabraut post-smolt facility completion; 31 Mar 2027 leverage covenant (≤4.50x) |
| Ongoing | Fish Pool forward prices; North America share post-tariff; any SalMar strategic action |
Analyst verdict
Icelandic Salmon is a recovering, sub-scale salmon farmer with high-quality infrastructure trapped in an uncertain regulatory regime. The operating evidence of 2026 is genuinely encouraging: volumes are rebuilding toward a guided 21,300 tonnes, half-year operating cash flow has turned positive, net debt has started to fall, and unit losses have narrowed from more than EUR 2/kg to well under EUR 1/kg despite a further disease incident. The infrastructure — smolt capacity for up to 30,000 tonnes, a 30,000-tonne harvest plant, full certification, and a sales team now attracting third-party volumes — is built for a company considerably larger than today's earnings base. Valuation on asset metrics, at roughly EUR 13,000 per tonne of licensed biomass and about 1.5x book, is undemanding for a SalMar-controlled operator.
Against this, the investment case has lost its main growth leg. Management itself has suspended the 26,000-tonne plan, the legislative process failed in 2026, and the resource tax keeps rising. The balance sheet has absorbed two loss years: leverage has more than doubled since 2023 and the company relies on covenant amendments whose next step-downs fall in September 2026 and March 2027. Biology has been the swing factor in each of the last three years and there is no hard evidence yet that the risk has structurally reduced.
Net assessment: the stock is a call option on (i) a clean 2025-generation harvest in H2 2026 and (ii) Icelandic regulatory normalisation, with SalMar providing a downside backstop but also controlling the terms of any recapitalisation. Investors with tolerance for illiquidity (free float under 5% outside the top 20 holders) may find the asset value compelling, but the near-term risk/reward hinges on the Q3–Q4 2026 cost delivery and covenant outcome. Until those are visible, a neutral stance with a positive bias toward an asset-backed recovery is warranted. This is an analytical assessment, not investment advice.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Prior roles / background | Shareholding (30 Jun 2026) |
|---|---|---|---|---|
Bjørn Hembre | CEO, Icelandic Salmon AS and Arnarlax ehf. | — | — | 32,900 shares (0.11%) via IVMA AS |
Róbert Benedikt Róbertsson | CFO | Appointed during H1 2026 (announced around late 2025/early 2026) | Succeeded interim CFO Edvin Aspli | Not listed |
Johnny Indergaard | COO SeaWater | — | — | 650 shares |
Rúnar Ingi Pétursson | COO Harvest Plant | — | — | 750 shares |
Edvin Aspli (former) | Interim CFO | 2025 – H1 2026 | Signed Annual Report 2025 release as interim CFO | — |
Jónas Heiðar Birgisson (former) | CFO | Until 2025 | Led EUR 100m sustainability-linked refinancing (2023) | — |
Board of Directors
| Name | Role | Affiliation / independence assessment | Shareholding |
|---|---|---|---|
Leif-Inge Nordhammer | Chairman | Former President/CEO of SalMar; joined board Oct 2020 — not independent of the majority shareholder | Indirect via minority stake in SalMar |
Gustav Witzøe | Board member | Founder of SalMar; indirectly owns approx. 92.6% of Kverva AS, which via Kverva Industries holds about 44.3% of SalMar — not independent (controlling-shareholder representative) | Indirect |
Ulrik Steinvik | Board member | SalMar-affiliated (indirect SalMar stake) — not independent of majority holder | Indirect |
Kjartan Ólafsson | Board member | Icelandic investor and co-founder-era shareholder; holds 550,000 shares (1.78%) via Berg Fjárfesting/Gyða ehf. — independent of SalMar but a significant shareholder | 1.78% |
Espen Weyergang Marcussen | Board member | Minority stake via Pactum Vekst AS (2.27% holder) — independent of SalMar | Indirect |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Spring 2025 | "Organizational change in Arnarlax ehf." announced | — |
| 2025 | CFO Jónas Heiðar Birgisson departs; Edvin Aspli interim CFO | Interim CFO presented Q2 2025 and signed AR 2025 release |
H1 2026 | Róbert Benedikt Róbertsson appointed CFO | Permanent CFO appointment; presents Q1 and Q2 2026 |
18 Jun 2026 | All board members re-elected | Board stability |
Major Shareholders
| Rank | Holder | Shares | Stake (%) |
|---|---|---|---|
| 1 | SalMar ASA | 16,248,152 | 52.48 |
| 2 | J.P. Morgan SE (nominee) | 2,480,353 | 8.01 |
| 3 | Íslandsbanki hf. (nominee) | 2,355,413 | 7.61 |
| 4 | Clearstream Banking S.A. (nominee) | 2,293,667 | 7.41 |
| 5 | Holta Invest AS | 1,149,133 | 3.71 |
| 6 | Surfside Holding AS | 703,131 | 2.27 |
| 7 | Pactum Vekst AS | 701,983 | 2.27 |
| 8 | MP Pensjon PK | 619,706 | 2.00 |
| 9 | Nima Invest AS | 606,512 | 1.96 |
| 10 | Roth | 599,661 | 1.94 |
Competitive Landscape
Key Competitors
| Competitor | Segment / geography | Relationship to ISL | Scale indicator | Positioning |
|---|---|---|---|---|
Arctic Fish (AFISH) | Iceland, Westfjords sea farming | Direct; Mowi-controlled | 29,800 t MAB; 2025 harvest approx. 14.8kt (derived: 10,561 t 9M + 4.2kt Q4); 2026 guidance 17.5kt; NIBD EUR 140m | Larger licence base in Westfjords; new harvest plant |
Kaldvik (formerly Ice Fish Farm) | Iceland, East fjords | Direct; Måsøval-backed | 2025 harvest 17,105 t; revenue EUR 114.4m; EBIT minus EUR 10.3m | Largest Icelandic producer by 2025 volume |
Háafell | Iceland, Ísafjarðardjúp | Direct (local) | — | Small, Westfjords |
Land-based Icelandic projects (e.g., First Water, Laxey, Samherji's land-based project) | Iceland, land-based RAS/flow-through | Emerging competitors for Icelandic-origin supply | Not disclosed / early stage | Not subject to sea-licence politics |
Mowi ASA | Norway, Scotland, Faroes, Canada, Chile, Iceland (via Arctic Fish) | Global price-setter | World's largest farmer | Integrated incl. value-added processing |
SalMar ASA | Norway, Iceland, Scotland (SSF) | Parent and market peer | 2025 harvest 300,900 t; Q4 2025 op EBIT NOK 1,834m | Global top-2 |
Lerøy Seafood Group | Norway | Market competitor | Large integrated | Strong downstream |
Grieg Seafood | Norway, Canada | Market competitor | Mid-size | Restructuring footprint |
Bakkafrost | Faroe Islands, Scotland | Closest North Atlantic island analogue | Large; premium price | Cold-water island producer, high margins historically |
Måsøval | Norway (and Iceland via Kaldvik) | Indirect | Mid-size | — |
“—” = not publicly disclosed.
Peer Comparison FY2025
| Metric | Icelandic Salmon | Arctic Fish | Kaldvik | SalMar (group) |
|---|---|---|---|---|
Harvest 2025 (thousand tgw) | 12.7 | 14.8 | 17.1 | 300.9 |
Revenue 2025 (EUR Mn) | 90.0 | — | 114.4 | — |
Revenue growth 2025 (%) | -11.3 | — | 6.2 | — |
Operational EBIT / EBIT 2025 (EUR Mn) | -18.2 | -10.3 | -10.3 | — |
EBIT margin 2025 (%) | -20.2 | — | -9.0 | — |
MAB licences (thousand t) | 23.7 | 29.8 | — | — |
2026 volume guidance (thousand tgw) | 21.3 | 17.5 | — | — |



